GlassScriptPhysician profile
Wanda C Leonhardt
NPI 1164532511
$2,082.92
in general payments reported to CMS, 2019-2025
9 companies · $352 in 2025
The $352 reported for 2025 was more than what 95% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $264 · 2022: $491 · 2023: $730 · 2024: $245 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,327.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $574.45 | 2023-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Neurocrine Biosciences, INC. | $383.13 | 2021-2023 | Ingrezza |
| Abbvie INC. | $349.17 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $164.24 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $125.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $123.36 | 2023 | Spravato |
| E.R. Squibb & Sons, L.L.C. | $122.84 | 2025 | Cobenfy |
| Axsome Therapeutics, INC. | $120.74 | 2025 | Auvelity |
| Alkermes, INC. | $119.99 | 2024 | Lybalvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanda Leonhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.